CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
Masimo O3 Regional Oximeterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04584788
NCT04584788N/ACompleted

A Single-Center, Prospective Study in Healthy Volunteers for Validation of the O3 Regional Somatic Tissue Oxygenation Monitor

Masimo Corporation·interventional·Posted Oct 14, 2020·Updated Jun 27, 2022

In Brief

A clinical study evaluating Masimo O3 Regional Oximeter for Oxygen Deficiency. Completed, enrolled 37 participants across 1 site.

Detailed Summary

Testing the absolute accuracy of the Masimo O3 regional oximeter in reading somatic tissue oxygenation in healthy volunteers under controlled hypoxia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 14, 2020
Enrollment StartNov 30, 2020
Primary CompletionJun 2, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.7 years ago

Interventions

Masimo O3 Regional Oximeterdevice

Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors.